2:19 PM
 | 
Apr 25, 2017
 |  BC Extra  |  Financial News

Sienna's series B round brings in $40M

Dermatology company Sienna Biopharmaceuticals Inc. (Westlake Village, Calif.) raised $40 million in a series B round led by Arch Venture Partners and Venvest Capital. Also participating were...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >